Loss of connectivity in cancer co-expression networks

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Anglani, Roberto ^a   Creanza, Teresa M ^a,b   Liuzzi, Vania C ^a   Piepoli, Ada ^c   Panza, Anna ^c   Andriulli, Angelo ^c   Ancona, Nicola ^a  

^a INSTITUTE OF INTELLIGENT SYSTEMS FOR AUTOMATION   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR MARKER;

ARTICLE; COLORECTAL CANCER; GENE EXPRESSION PROFILING; HUMAN; LUNG NON SMALL CELL CANCER; NEOPLASM; PANCREAS CANCER; PHENOTYPE; PROTEIN PROCESSING; STOMACH CANCER; TUMOR GENE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, NEOPLASM; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84900325907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087075     Document Type: Article

References (54)

1. Kitano H (2002) Computational systems biology. Nature 420: 206-210.
2. Kitano H (2012) Systems biology powered by arti-cial intelligence. In: PRICAI 2012: Trends in Artificial Intelligence - 12th Pacific Rim International Conference on Artificial Intelligence, Kuching, Malaysia, September 3-7, 2012. Proceedings. Springer, Lecture Notes in Computer Science, p. 1.
3. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121. (Pubitemid 32397092)
4. Liang P, Pardee AB (2003) Analysing differential gene expression in cancer. Nat Rev Cancer 3: 869-876. (Pubitemid 37376983)
5. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. (Pubitemid 41528093)
6. Abatangelo L, Maglietta R, Distaso A, D'Addabbo A, Creanza TM, et al. (2009) Comparative study of gene set enrichment methods. BMC Bioinformatics 10: 275.
7. de la Fuente A (2010) From 'differential expression' to 'differential networking' - identification of dysfunctional regulatory networks in diseases. Trends Genet 26: 326-333.
8. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, et al. (1992) Apc mutations occur early during colorectal tumorigenesis. Nature 359: 235-237.
9. Fearon ER, Dang CV (1999) Cancer genetics: Tumor suppressor meets oncogene. Current Biology 9: R62-R65. (Pubitemid 29083525)
10. Fearnhead NS (2001) The abc of apc. Human Molecular Genetics 10: 721-733.
11. Barabási AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113.
12. Bandyopadhyay S, Mehta M, Kuo D, Sung MK, Chuang R, et al. (2010) Rewiring of genetic networks in response to dna damage. Science 330: 1385-1389.
13. Califano A (2011) Rewiring makes the difference. Mol Syst Biol 7: 463.
14. Ideker T, Krogan NJ (2012) Differential network biology. Mol Syst Biol 8: 565.
15. Luscombe NM, Babu MM, Yu H, Snyder M, Teichmann SA, et al. (2004) Genomic analysis of regulatory network dynamics reveals large topological changes. Nature 431: 308-312. (Pubitemid 39265665)
16. Xulvi-Brunet R, Li H (2010) Co-expression networks: graph properties and topological comparisons. Bioinformatics 26: 205-214.
17. Choi JK, Yu U, Yoo OJ, Kim S (2005) Differential coexpression analysis using microarray data and its application to human cancer. Bioinformatics 21: 4348-4355. (Pubitemid 41782924)
18. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, et al. (2009) Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 27: 199-204.
19. West J, Bianconi G, Severini S, Teschendorff AE (2012) Differential network entropy reveals cancer system hallmarks. Sci Rep 2: 802.
20. Hudson NJ, Reverter A, Dalrymple BP (2009) A differential wiring analysis of expression data correctly identifies the gene containing the causal mutation. PLoS Comput Biol 5: e1000382.
21. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 57: pp. 289-300.
22. Markowitz SD, Bertagnolli MM (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361: 2449-2460.
23. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183. (Pubitemid 38337497)
24. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M (2012) Kegg for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40: D109-D114.
25. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113. (Pubitemid 350134889)
26. Sharma SV, Bell DW, Settleman J, Haber DA (2007) Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7: 169-181.
27. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
28. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359: 1367-1380.
29. Chang JT, Nevins JR (2006) Gather: a systems approach to interpreting genomic signatures. Bioinformatics 22: 2926-2933. (Pubitemid 44811565)
30. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major smad pathways in tgf-beta superfamily signalling. Genes to cell 7: 1191-1204.
31. Kondo M, Cubillo E, Tobiume K, Shirakihara T, Fukuda N, et al. (2004) A role for id in the regulation of tgf-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death Di-er 11: 1092-1101.
32. Grützmann R, Boriss H, Ammerpohl O, Lüttges J, Kalthoff H, et al. (2005) Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene 24: 5079-5088. (Pubitemid 41129085)
33. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005) Online mendelian inheritance in man (omim), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33: D514-D517. (Pubitemid 40207927)
34. Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, et al. (2013) Evaluation of dna from the papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med 5: 167ra4.
35. James RG, Biechele TL, Conrad WH, Camp ND, Fass DM, et al. (2009) Bruton's tyrosine kinase revealed as a negative regulator of wnt-beta-catenin signaling. Sci Signal 2: ra25.
36. Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, et al. (2005) Correlation of wnt-2 expression and beta-catenin intracellular accumulation in chinese gastric cancers: relevance with tumour dissemination. Cancer Lett 223: 339-347. (Pubitemid 40719632)
37. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, et al. (2001) Nuclear factor-kappab p65 (rela) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7: 4136-4142. (Pubitemid 34044638)
38. Kawajiri K, Kobayashi Y, Ohtake F, Ikuta T, Matsushima Y, et al. (2009) Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in apcmin/+ mice with natural ligands. Proc Natl Acad Sci U S A 106: 13481-13486.
39. Shin SM, Chung YJ, Oh ST, Jeon HM, Hwang LJ, et al. (2006) Hccr-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis. Gastroenterology 130: 2074-2086. (Pubitemid 43816968)
40. Maglott D, Ostell J, Pruitt KD, Tatusova T (2007) Entrez gene: gene-centered information at ncbi. Nucleic Acids Res 35: D26-D31. (Pubitemid 46056164)
41. Starczynowski DT, Lockwood WW, Deléhouzée S, Chari R, Wegrzyn J, et al. (2011) Traf6 is an amplified oncogene bridging the ras and nf- kb pathways in human lung cancer. J Clin Invest 121: 4095-4105.
42. Giaccone G, Zucali PA (2008) Src as a potential therapeutic target in non-smallcell lung cancer. Ann Oncol 19: 1219-1223. (Pubitemid 351911949)
43. Chen LM, Kuo CH, Lai TY, Lin YM, Su CC, et al. (2011) Rankl increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation. J Cell Biochem 112: 933-941.
44. Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, et al. (2007) Death-receptor o-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand apo2l/trail. Nat Med 13: 1070-1077. (Pubitemid 47517508)
45. Stern HM, Padilla M, Wagner K, Amler L, Ashkenazi A (2010) Development of immunohistochemistry assays to assess galnt14 and fut3/6 in clinical trials of dulanermin and drozitumab. Clin Cancer Res 16: 1587-1596.
46. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
47. Wei P, Tang H, Li D (2012) Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data. PLoS One 7: e46887.
48. Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94. (Pubitemid 46164746)
49. Benz CC (1998) Transcription factors and breast cancer. Endocrine Related Cancer 5: 271-282.
50. Zheng R, Blobel GA (2010) Gata transcription factors and cancer. Genes Cancer 1: 1178-1188.
51. Dunn GP, Koebel CM, Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6: 836-848. (Pubitemid 44631652)
52. Thibodeau J, Bourgeois-Daigneault MC, Lapointe R (2012) Targeting the mhc class ii antigen presentation pathway in cancer immunotherapy. Oncoimmunology 1: 908-916.
53. Hollander M, Wolfe DA (1999) Nonparametric Statistical Methods (Wiley Series in Probability and Statistics). Wiley-Interscience.
54. Good P (2000) Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses (Springer Series in Statistics). Springer.